[ RECIPIENT ENTITY RECORD ]

Telavant

VERIFIED NODE ID: 001355 · telavant
R TARGET NODE — CAPITAL RECIPIENT
Telavant
Company United States
Recipient Type
Company
Primary Jurisdiction
United States
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Telavant
Entity Type Company
Jurisdiction United States
Recipient Intelligence Summary

Telavant is a biotechnology company focused on developing innovative therapies for patients with inflammatory and fibrotic diseases. The firm was established through a partnership to advance specialized medical treatments for chronic conditions. It is a significant recipient of institutional healthcare capital through strategic industry acquisitions.

Capital Influx Log (Transactions)
Date Type Amount
19 May 2026 EQUITY $7.1B